Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Evaluating GLP-1 Receptor Agonist Semaglutide in Phase 3 Settings for Alzheimer Disease: The EVOKE Trials Isabella Ciccone, MPH

Published Date: 29 Nov 2025

Topline results of the EVOKE and EVOKE+ studies of semaglutide will be presented at the 2025 Clinical Trials on Alzheimer’s Disease Conference, held December 1-4, in San Diego, California.

Phase 4 Data Support Effectiveness of Deutetrabenazine in Managing Tardive Dyskinesia, Chorea Louie Pasculli

Published Date: 29 Nov 2025

Real-world data from Teva Pharmaceuticals’ IMPACT-TD Registry showed that deutetrabenazine and its extended-release formulation led to significant reductions of involuntary movements and improved quality of life for adults with tardive dyskinesia.

Exploring A Potential New Method to Evaluate CTE Progression in Living Patients Louie Pasculli, Shae Datta, MD

Published Date: 29 Nov 2025

Shae Datta, MD, co-director of the NYU Concussion Center, explained new findings regarding potential CTE diagnosis in living patients.

FDA Awards Accelerated Approval to Sibeprenlimab in IgA Nephropathy

Published Date: 29 Nov 2025

FDA Awards Accelerated Approval to Sibeprenlimab in IgA Nephropathy

AI Tools Fall Short for Dietary Recommendations for Managing IBS

Published Date: 29 Nov 2025

AI Tools Fall Short for Dietary Recommendations for Managing IBS

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Published Date: 29 Nov 2025

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Expert Consensus Provides Recommendations on Dermoscopy Standards for PAs

Published Date: 29 Nov 2025

Expert Consensus Provides Recommendations on Dermoscopy Standards for PAs

How to Recognize and Treat Atopic Dermatitis in Patients with Skin of Color

Published Date: 29 Nov 2025

How to Recognize and Treat Atopic Dermatitis in Patients with Skin of Color

Knowledge Hub

Oncology

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Precision cancer care using theranostics and radioligand therapy enhances targeted treatment and patient outcomes.

Oncology

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Explore strategies for optimizing oncology trials, enhancing recruitment, decentralization, diversity, and patient-centered care.

Oncology

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

Enhance cancer care with multidisciplinary strategies, supportive therapies, and patient-centered interventions for better outcomes.

Oncology

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Explore the future of cancer care with genetics, supportive strategies, and emerging therapies for patients.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Evaluating GLP-1 Receptor Agonist Semaglutide in Phase 3 Settings for Alzheimer Disease: The EVOKE Trials Isabella Ciccone, MPH

Phase 4 Data Support Effectiveness of Deutetrabenazine in Managing Tardive Dyskinesia, Chorea Louie Pasculli

Exploring A Potential New Method to Evaluate CTE Progression in Living Patients Louie Pasculli, Shae Datta, MD

FDA Awards Accelerated Approval to Sibeprenlimab in IgA Nephropathy

AI Tools Fall Short for Dietary Recommendations for Managing IBS

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Expert Consensus Provides Recommendations on Dermoscopy Standards for PAs

How to Recognize and Treat Atopic Dermatitis in Patients with Skin of Color

Knowledge Hub

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Evaluating GLP-1 Receptor Agonist Semaglutide in Phase 3 Settings for Alzheimer Disease: The EVOKE Trials Isabella Ciccone, MPH

Phase 4 Data Support Effectiveness of Deutetrabenazine in Managing Tardive Dyskinesia, Chorea Louie Pasculli

Exploring A Potential New Method to Evaluate CTE Progression in Living Patients Louie Pasculli, Shae Datta, MD

FDA Awards Accelerated Approval to Sibeprenlimab in IgA Nephropathy

AI Tools Fall Short for Dietary Recommendations for Managing IBS

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Expert Consensus Provides Recommendations on Dermoscopy Standards for PAs

How to Recognize and Treat Atopic Dermatitis in Patients with Skin of Color

Knowledge Hub

Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides

Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization

Optimizing Cancer Care: Multidisciplinary Approaches and Supportive Strategies

The Future of Cancer Care: Genetics, Support Systems, and Emerging Therapies

Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views